As the founder of the DIRT (Direct, Inspiring, Reachable, Teachable) model of advocacy, Bryan C. Jones, has traveled the ...

The Centers for Disease Control and Prevention has awarded a $1.4 million grant to a University of Albany professor, Melonie ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Learn about HIV stages, prevention methods and treatment options including modern testing approaches for better health management in 2025.

A peer-to-peer program successfully trained and mobilized volunteers to distribute information about PrEP to people not often ...

A spokesperson for Gilead Sciences said in an email that lenacapavir is being studied for the prevention of HIV and, if approved, it has the potential to be the first and only twice-yearly HIV ...

As the new cases and related deaths fall in sub-Saharan Africa, the virus is rearing its head elsewhere. What's the cause?

HIV stigma and discrimination continue to harm the lives of people living with HIV, and hinder efforts to stem the epidemic ...

In a video series at the center of a recently launched campaign, the company pairs doctors, people living with HIV and other advocates for sit-down conversations about diagnosis, prevention ...

the study delved into the transformative potential of leveraging social influence to de-medicalize HIV prevention tools and address deep-seated stigma. The Le Kip Kip campaign emerged as a bold ...

However, the drug does not cure existing HIV infection or AIDS, Dr. Colleen Kelley, the lead author of this study, told USA TODAY. Lenacapavir helps prevent HIV infection by disrupting the ...